PRKAA2 and metabolic dysfunction-associated steatotic liver disease: Previous research has identified that during the “second hit” phase in MASLD progression, the AMPK signaling pathway, functioning as a metabolic regulator that regulates energy homeostasis, is intricately implicated in the entire spectrum of MASLD’s onset and progression.